Evidence map›Paper›PMID 25944897›Full record

ArticleThe Journal of biological chemistry2015

Coordinated Regulation of Vasopressin Inactivation and Glucose Uptake by Action of TUG Protein in Muscle.

Estifanos N Habtemichael, Abel Alcázar-Román, Bradley R Rubin, Laura R Grossi, Jonathan P Belman, Omar Julca, Michael G Löffler, Hongjie Li, Nai-Wen Chi, Varman T Samuel and 1 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Estifanos N HabtemichaelFrom the Section of Endocrinology and Metabolism, Department of Internal Medicine, and.
Abel Alcázar-RománFrom the Section of Endocrinology and Metabolism, Department of Internal Medicine, and.
Bradley R RubinFrom the Section of Endocrinology and Metabolism, Department of Internal Medicine, and Department of Cell Biology, Yale University School of Medicine, New Haven, Connecticut 06520-8020.
Laura R GrossiFrom the Section of Endocrinology and Metabolism, Department of Internal Medicine, and Department of Cell Biology, Yale University School of Medicine, New Haven, Connecticut 06520-8020.
Jonathan P BelmanFrom the Section of Endocrinology and Metabolism, Department of Internal Medicine, and Department of Cell Biology, Yale University School of Medicine, New Haven, Connecticut 06520-8020.
Omar JulcaFrom the Section of Endocrinology and Metabolism, Department of Internal Medicine, and Department of Cell Biology, Yale University School of Medicine, New Haven, Connecticut 06520-8020.
Michael G LöfflerFrom the Section of Endocrinology and Metabolism, Department of Internal Medicine, and.
Hongjie LiFrom the Section of Endocrinology and Metabolism, Department of Internal Medicine, and.
Nai-Wen Chithe Veterans Affairs San Diego Healthcare System and Department of Medicine, University of California, San Diego, California 92093, and.
Varman T SamuelFrom the Section of Endocrinology and Metabolism, Department of Internal Medicine, and the Veterans Affairs Medical Center, West Haven, Connecticut 06516.
Jonathan S BoganFrom the Section of Endocrinology and Metabolism, Department of Internal Medicine, and Department of Cell Biology, Yale University School of Medicine, New Haven, Connecticut 06520-8020, jonathan.bogan@yale.edu.ORCID http://orcid.org/0000-0001-6463-8466
Yale University · USUniversity of California San Diego · USVeterans Health Administration · US

Funding

Yale Diabetes Research CenterP30DK045735 · NIDDK · YALE UNIVERSITY · PI Kevan C Herold · 1993 to 2026
$44.0M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007205 · NIGMS · YALE UNIVERSITY · PI KAZMIERCZAK, BARBARA I · 1985 to 2019
$42.9M
Renal Physiology and Phenotyping CoreP30DK079310 · NIDDK · YALE UNIVERSITY · PI ARONSON, PETER S. · 2008 to 2022
$16.8M
DIABETES MELLITUS &DISORDERS OF METABOLISMT32DK007058 · NIDDK · YALE UNIVERSITY · PI SONIA CAPRIO, Kevan C Herold · 1986 to 2026
$9.6M
Yale Mouse Metabolic Phenotyping CenterU24DK059635 · NIDDK · YALE UNIVERSITY · PI SHULMAN, GERALD I · 2001 to 2015
$8.9M
Vesicle Translocation and the Metabolic SyndromeR01DK092661 · NIDDK · YALE UNIVERSITY · PI BOGAN, JONATHAN · 2012 to 2018
$2.0M
Regulation of insulin sensitivity by TUG acetylationR21AG041383 · NIA · YALE UNIVERSITY · PI BOGAN, JONATHAN · 2012 to 2013
$446k
TUG-mediated GLUT4 glucose transporter trafficking and regulation by post-translaF30DK093198 · NIDDK · YALE UNIVERSITY · PI BELMAN, JONATHAN PHILIP · 2011 to 2012
$88k
Cellular mechanisms for increased gluconeogenesis in type 2 diabetes mellitus: the role of lipid induced pyruvate carboxylase acetylation in increasing hepatic gluconeogenic capacity.I01BX000901 · VA · VA CONNECTICUT HEALTHCARE SYSTEM · PI SAMUEL, VARMAN T · 2012 to 2020
–
Regulation of energy homeostasis and adiposity by a Golgi-associated PARP enzymeI01BX000702 · VA · VA SAN DIEGO HEALTHCARE SYSTEM · PI CHI, NAI-WEN · 2009 to 2013
–
BLRD VA I01 BX000702BLRD VA I01 BX000901NIA NIH HHS R21 AG041383NIA NIH HHS R21AG041383NIDDK NIH HHS F30 DK093198NIDDK NIH HHS F30DK093198NIDDK NIH HHS P30 DK045735NIDDK NIH HHS P30 DK079310NIDDK NIH HHS P30DK079310NIDDK NIH HHS P30 DK45735NIDDK NIH HHS R01 DK092661NIDDK NIH HHS R01DK092661NIDDK NIH HHS T32 DK007058NIDDK NIH HHS T32DK007058NIDDK NIH HHS U24 DK059635NIGMS NIH HHS T32 GM007205
6 · The paper itself

Abstract

In adipose and muscle cells, insulin stimulates the exocytic translocation of vesicles containing GLUT4, a glucose transporter, and insulin-regulated aminopeptidase (IRAP), a transmembrane aminopeptidase. A substrate of IRAP is vasopressin, which controls water homeostasis. The physiological importance of IRAP translocation to inactivate vasopressin remains uncertain. We previously showed that in skeletal muscle, insulin stimulates proteolytic processing of the GLUT4 retention protein, TUG, to promote GLUT4 translocation and glucose uptake. Here we show that TUG proteolysis also controls IRAP targeting and regulates vasopressin action in vivo. Transgenic mice with constitutive TUG proteolysis in muscle consumed much more water than wild-type control mice. The transgenic mice lost more body weight during water restriction, and the abundance of renal AQP2 water channels was reduced, implying that vasopressin activity is decreased. To compensate for accelerated vasopressin degradation, vasopressin secretion was increased, as assessed by the cosecreted protein copeptin. IRAP abundance was increased in T-tubule fractions of fasting transgenic mice, when compared with controls. Recombinant IRAP bound to TUG, and this interaction was mapped to a short peptide in IRAP that was previously shown to be critical for GLUT4 intracellular retention. In cultured 3T3-L1 adipocytes, IRAP was present in TUG-bound membranes and was released by insulin stimulation. Together with previous results, these data support a model in which TUG controls vesicle translocation by interacting with IRAP as well as GLUT4. Furthermore, the effect of IRAP to reduce vasopressin activity is a physiologically important consequence of vesicle translocation, which is coordinated with the stimulation of glucose uptake.

Indexed as

3T3-L1 CellsAnimalsBiological TransportCarrier ProteinsCystinyl AminopeptidaseExocytosisGlucoseGlucose Transporter Type 4InsulinIntracellular Signaling Peptides and ProteinsMiceMice, Inbred C57BLMuscle, SkeletalVasopressinsAspscr1 protein, mouseCarrier ProteinsCystinyl AminopeptidaseGlucoseGlucose Transporter Type 4InsulinIntracellular Signaling Peptides and Proteinsleucyl-cystinyl aminopeptidaseVasopressinsaminopeptidaseglucose transporter type 4 (GLUT4)insulinmembrane traffickingskeletal muscletranslocationvasopressin

Identifiers

PMID25944897
PMCPMC4505512
OpenAlexW1512840673

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.